Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Complement component 3 (C 3) and diabetes mellitus.

S Krantz1, F Stelter, M Lober

  • 1Institute of Biochemistry, Ernst Moritz Arndt University Greifswald, GDR.

Experimental and Clinical Endocrinology
|March 1, 1988
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

ZEB1 stratifies the response to Sorafenib and Mdivi-1 combination therapy in hepatocellular carcinoma.

Scientific reports·2025
Same author

Rewetting does not return drained fen peatlands to their old selves.

Nature communications·2021
Same author

[Treatment of carbon monoxide poisoning in Germany : A retrospective single center analysis].

Der Anaesthesist·2019
Same author

Plasmonic Purcell effect reveals obliquely ordered phosphorescent emitters in Organic LEDs.

Scientific reports·2017
Same author

Autoantibody-defined risk for Type 1 diabetes mellitus in a general population of schoolchildren: results of the Karlsburg Type 1 Diabetes Risk Study after 18 years.

Diabetic medicine : a journal of the British Diabetic Association·2014
Same author

Supply chain and marketing of sea grapes, <i>Caulerpa racemosa</i> (Forsskål) J. Agardh (Chlorophyta: Caulerpaceae) in Fiji, Samoa and Tonga.

Journal of applied phycology·2014
Same journal

Autoantibodies to glutamate decarboxylase detected in diabetes-prone BB/OK rats do not distinguish onset of diabetes.

Experimental and clinical endocrinology·1994
Same journal

Urinary excretion of hydroxy-pyridinium cross-links of collagen reflects skeletal growth velocity in normal children.

Experimental and clinical endocrinology·1994
Same journal

Tissue regenerates of adrenal cortex with a physiological function twelve years after bilateral total adrenalectomy for Cushing's syndrome.

Experimental and clinical endocrinology·1994
Same journal

Thyroid hormone deiodination in target tissues--a regulatory role for the trace element selenium?

Experimental and clinical endocrinology·1994
Same journal

Effects of music treatment on salivary cortisol in patients exposed to pre-surgical stress.

Experimental and clinical endocrinology·1994
Same journal

Systolic ventricular function in acute hypothyroidism: a study using Doppler echocardiography.

Experimental and clinical endocrinology·1994
See all related articles

This study found no evidence that complement factor 3 (C3) genes affect diabetes risk or complications. However, C3 levels were slightly elevated in both Type 1 and Type 2 diabetes patients.

Area of Science:

  • Immunogenetics
  • Metabolic Disorders

Background:

  • Complement factor 3 (C3) is a key component of the innate immune system.
  • Alterations in complement pathways have been implicated in various inflammatory and autoimmune conditions, including diabetes mellitus.
  • Understanding the role of C3 in diabetes susceptibility and progression is crucial for developing targeted therapies.

Purpose of the Study:

  • To investigate the association between complement factor 3 (C3) gene polymorphisms and susceptibility to Type 1 diabetes (IDDM) and Type 2 diabetes mellitus (NIDDM).
  • To evaluate the relationship between C3 levels, C3 split products, and the presence of late diabetic complications.
  • To assess C3 plasma concentrations and proteolysis in diabetic patients and their relatives.

Main Methods:

  • Phenotype and allele frequencies of C3 were analyzed in a cohort of European individuals, including patients with Type 1 and Type 2 diabetes, their relatives, and healthy controls.

Related Experiment Videos

  • Plasma C3 levels and the presence of C3 split products were measured.
  • Statistical analyses were performed to determine associations between C3 genotypes, C3 levels, and diabetes status or complications.

    • Main Results:

    • No significant evidence was found to suggest that C3 gene polymorphisms influence susceptibility to Type 1 or Type 2 diabetes or their late complications.
    • Plasma C3 levels were found to be slightly elevated in both Type 1 and Type 2 diabetes patients compared to controls.
    • C3 split products, indicative of C3 proteolysis, were detected in a significant percentage of patients with newly diagnosed Type 1 diabetes and in a smaller proportion of Type 2 diabetes patients.

    Conclusions:

    • C3 gene variations do not appear to play a major role in the genetic predisposition to Type 1 or Type 2 diabetes in the studied European population.
    • Elevated C3 levels and evidence of C3 activation (proteolysis) are present in diabetic patients, suggesting a potential role for the complement system in diabetes pathophysiology or its complications.
    • Further research is warranted to elucidate the precise role of complement activation in diabetes and its long-term consequences.